Exact Sciences Stock Buy Hold or Sell Recommendation

EXAS Stock  USD 69.06  2.18  3.26%   
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding EXACT Sciences is 'Hold'. Macroaxis provides EXACT Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EXAS positions. The advice algorithm takes into account all of EXACT Sciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting EXACT Sciences' buy or sell advice are summarized below:
Real Value
67.04
Target Price
106.38
Hype Value
69.06
Market Value
69.06
Naive Value
69.38
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell EXACT Sciences given historical horizon and risk tolerance towards EXACT Sciences. When Macroaxis issues a 'buy' or 'sell' recommendation for EXACT Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out EXACT Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
In addition, we conduct extensive research on individual companies such as EXACT and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

Execute EXACT Sciences Buy or Sell Advice

The EXACT recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on EXACT Sciences. Macroaxis does not own or have any residual interests in EXACT Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EXACT Sciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell EXACT SciencesBuy EXACT Sciences
Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon EXACT Sciences has a Risk Adjusted Performance of (0), Jensen Alpha of (0.26), Total Risk Alpha of (0.68) and Treynor Ratio of (0.04)
Macroaxis provides unbiased advice on EXACT Sciences that should be used to complement current analysts and expert consensus on EXACT Sciences. Our trade recommendation engine determines the company's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure EXACT Sciences is not overpriced, please confirm all EXACT Sciences fundamentals, including its shares outstanding, net income, price to earnings to growth, as well as the relationship between the price to book and current ratio . Given that EXACT Sciences has a price to earning of (38.17) X, we urge you to verify EXACT Sciences market performance and probability of bankruptcy to ensure the company can sustain itself for few more years given your latest risk tolerance and investing horizon.

EXACT Sciences Trading Alerts and Improvement Suggestions

EXACT Sciences generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B.
Over 89.0% of the company shares are held by institutions such as insurance companies
Latest headline from zacks.com: Ligand Down 15.5 percent Since Last Earnings Report Can It Rebound

EXACT Sciences Returns Distribution Density

The distribution of EXACT Sciences' historical returns is an attempt to chart the uncertainty of EXACT Sciences' future price movements. The chart of the probability distribution of EXACT Sciences daily returns describes the distribution of returns around its average expected value. We use EXACT Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EXACT Sciences returns is essential to provide solid investment advice for EXACT Sciences.
Mean Return
-0.06
Value At Risk
-4.25
Potential Upside
4.01
Standard Deviation
2.72
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EXACT Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

EXACT Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as EXACT Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EXACT Sciences backward and forwards among themselves. EXACT Sciences' institutional investor refers to the entity that pools money to purchase EXACT Sciences' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Ameriprise Financial Inc2023-12-31
2.5 M
Sumitomo Mitsui Trust Holdings Inc2023-12-31
2.2 M
Amvescap Plc.2023-12-31
2.2 M
Allspring Global Investments Holdings, Llc2023-12-31
1.9 M
Goldman Sachs Group Inc2023-12-31
1.8 M
Nikko Asset Management Americas Inc2023-12-31
1.8 M
Citadel Advisors Llc2023-09-30
1.7 M
Norges Bank2023-12-31
1.6 M
Ensign Peak Advisors Inc2023-12-31
1.5 M
Vanguard Group Inc2023-12-31
17.6 M
Jpmorgan Chase & Co2023-12-31
16.7 M
Note, although EXACT Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EXACT Sciences Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash17.1M1.3B(1.2B)(73.0M)366.9M385.2M
Free Cash Flow(286.8M)72.1M(238.0M)(438.0M)31.9M33.5M
Depreciation50.2M163.4M180.3M197.6M206.6M216.9M
Other Non Cash Items48.9M721.3M202.0M33.8M(76.4M)(72.5M)
Capital Expenditures171.8M64.4M135.8M214.5M124.2M130.4M
Net Income(84.0M)(848.5M)(595.6M)(623.5M)(204.1M)(214.4M)
End Period Cash Flow177.5M1.5B315.8M242.8M609.7M640.2M
Change To Inventory(19.0M)(30.3M)(9.2M)(13.2M)(7.7M)(8.1M)
Investments1.0B(219.2M)(387.8M)278.8M49.7M52.2M
Dividends Paid17.2M18.4M(37.5M)(169.5M)(194.9M)(185.2M)
Change To Netincome106.5M777.6M195.3M181.3M208.5M131.1M
Net Borrowings236.4M975.5M(23.7M)50M57.5M54.6M
Change Receivables(27.9M)(100.5M)25.2M61.1M70.3M73.8M

EXACT Sciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EXACT Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EXACT Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EXACT stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.26
β
Beta against NYSE Composite1.57
σ
Overall volatility
2.79
Ir
Information ratio -0.07

EXACT Sciences Volatility Alert

EXACT Sciences exhibits very low volatility with skewness of 0.4 and kurtosis of 1.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EXACT Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EXACT Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

EXACT Sciences Fundamentals Vs Peers

Comparing EXACT Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EXACT Sciences' direct or indirect competition across all of the common fundamentals between EXACT Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as EXACT Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EXACT Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare EXACT Sciences to competition
FundamentalsEXACT SciencesPeer Average
Return On Equity-0.066-0.31
Return On Asset-0.0304-0.14
Profit Margin(0.08) %(1.27) %
Operating Margin(0.12) %(5.51) %
Current Valuation13.92 B16.62 B
Shares Outstanding181.53 M571.82 M
Shares Owned By Insiders1.00 %10.09 %
Shares Owned By Institutions89.47 %39.21 %
Number Of Shares Shorted6.52 M4.71 M
Price To Earning(38.17) X28.72 X
Price To Book3.77 X9.51 X
Price To Sales5.02 X11.42 X
Revenue2.5 B9.43 B
Gross Profit1.51 B27.38 B
EBITDA(13.13 M)3.9 B
Net Income(204.15 M)570.98 M
Cash And Equivalents728.04 M2.7 B
Cash Per Share4.11 X5.01 X
Total Debt2.55 B5.32 B
Debt To Equity0.77 %48.70 %
Current Ratio2.48 X2.16 X
Book Value Per Share17.34 X1.93 K
Cash Flow From Operations156.12 M971.22 M
Short Ratio3.00 X4.00 X
Earnings Per Share(1.17) X3.12 X
Price To Earnings To Growth(1.07) X4.89 X
Target Price89.91
Number Of Employees6.5 K18.84 K
Beta1.23-0.15
Market Capitalization12.54 B19.03 B
Total Asset6.47 B29.47 B
Retained Earnings(3.47 B)9.33 B
Working Capital679.67 M1.48 B
Note: Acquisition by Jeffrey Elliott of 5701 shares of EXACT Sciences subject to Rule 16b-3 [view details]

EXACT Sciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EXACT . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About EXACT Sciences Buy or Sell Advice

When is the right time to buy or sell EXACT Sciences? Buying financial instruments such as EXACT Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Total Stockholder Equity3.4B3.0B3.1B3.3B
Total Assets6.7B6.2B6.5B6.8B

Use Investing Ideas to Build Portfolios

In addition to having EXACT Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Construction Materials Thematic Idea Now

Construction Materials
Construction Materials Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
View All  Next Launch
When determining whether EXACT Sciences is a strong investment it is important to analyze EXACT Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EXACT Sciences' future performance. For an informed investment choice regarding EXACT Stock, refer to the following important reports:
Check out EXACT Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for EXACT Stock analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.17)
Revenue Per Share
13.876
Quarterly Revenue Growth
0.17
Return On Assets
(0.03)
Return On Equity
(0.07)
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.